why choose us

First received: November 03, 2023

Clinical Trial: Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Stage IIC Prostate Cancer AJCC v8

Study Type: INTERVENTIONAL


Official Title: Quantifying Optimal Relugolix Duration With Radiation in High Risk Prostate Cancer (QURE-PC)

Brief Summary: This phase II trial evaluates the best duration for relugolix to be given in combination with radiation therapy when treating patients with high risk prostate cancer.Prostate cancer is a hormonal influenced cancer.Part of the usual treatment for patients with prostate cancer is androgen deprivation therapy (ADT).ADT is used to lower the amount of testosterone in the body, because testosterone appears to help prostate cancer grow.Relugolix works to reduce testosterone levels, which may inhibit proliferation of…

Read more